K183704

Substantially Equivalent

RX-1 Rhythm Express Remote Cardiac Monitoring System

Applicant: VivaQuant, Inc.
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2018-12-31
Decision date: 2019-02-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St. Paul, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.